Overview

Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma

Status:
Recruiting
Trial end date:
2024-07-30
Target enrollment:
Participant gender:
Summary
This is an investigational, single arm study.
Phase:
Phase 4
Details
Lead Sponsor:
Tang-Du Hospital
Treatments:
Paclitaxel
Pembrolizumab